Loading institutional data...
Loading institutional data...
Held by 748 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $141.55 today, the market must believe free cash flow compounds 17.1%/yr for a decade (off $251M normalized FCF).
The market's 17.1% is more conservative than its 2-yr track record.
2-stage DCF · 0.07B shares · net debt $18M
mean 179.6% · volatility σ 220% · implied rate exceeded in 2/2 yrs
Central path = implied 17.1%/yr growth; shaded band = ±1σ (220%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.71B 100.0% | $2.07B 100.0% | $1.70B 100.0% | $1.31B 100.0% | $1.10B 100.0% | $904.4M 100.0% | $738.2M 100.0% | $563.8M 100.0% | $463.8M 100.0% | $367.0M 100.0% |
| Cost of Revenue | $768.2M 28.4% | $625.9M 30.2% | $537.2M 31.7% | $499.7M 38.3% | $346.7M 31.6% | $322.1M 35.6% | $257.9M 34.9% | $193.6M 34.3% | $186.6M 40.2% | $155.9M 42.5% |
| Gross Profit | $1.94B 71.6% | $1.45B 69.8% | $1.16B 68.3% | $805.6M 61.7% | $752.1M 68.4% | $582.3M 64.4% | $480.3M 65.1% | $370.2M 65.7% | $277.2M 59.8% | $211.1M 57.5% |
| Research & Development | $301.1M 11.1% | $219.6M 10.6% | $205.0M 12.1% | $180.2M 13.8% | $160.1M 14.6% | $146.8M 16.2% | $132.3M 17.9% | $94.8M 16.8% | $75.7M 16.3% | $55.7M 15.2% |
| Selling, General & Admin | $1.17B 43.0% | $917.2M 44.3% | $734.8M 43.3% | $587.8M 45.0% | $466.0M 42.4% | $384.0M 42.5% | $298.0M 40.4% | $248.0M 44.0% | $84.7M 18.3% | $71.6M 19.5% |
| Total Operating Expenses | — | — | — | — | — | — | $430.3M 58.3% | $342.8M 60.8% | $284.6M 61.4% | $221.8M 60.4% |
| Operating Income | $473.8M 17.5% | $308.9M 14.9% | $220.1M 13.0% | $37.6M 2.9% | $126.0M 11.5% | $51.5M 5.7% | $50.0M 6.8% | $27.4M 4.9% | -$7.4M -1.6% | -$10.7M -2.9% |
| Interest Expense | $59.4M 2.2% | $42.7M 2.1% | $36.2M 2.1% | $36.0M 2.8% | $61.7M 5.6% | $48.1M 5.3% | $34.6M 4.7% | $28.9M 5.1% | $21.2M 4.6% | $14.4M 3.9% |
| Interest & Investment Income | $34.7M 1.3% | $39.5M 1.9% | $28.6M 1.7% | $9.3M 0.7% | $500K 0.0% | — | — | — | — | — |
| Other Income (Expense), net | $14.3M 0.5% | -$5.5M -0.3% | $2.2M 0.1% | -$1.1M -0.1% | -$1.9M -0.2% | $3.3M 0.4% | $900K 0.1% | -$22.2M -3.9% | -$19.2M -4.1% | -$16.1M -4.4% |
| Pretax Income | $339.5M 12.5% | $300.2M 14.5% | $214.7M 12.7% | $9.8M 0.8% | $20.5M 1.9% | $9.7M 1.1% | $14.5M 2.0% | $5.2M 0.9% | -$26.6M -5.7% | -$26.8M -7.3% |
| Income Tax Expense | $92.4M 3.4% | -$118.1M -5.7% | $8.3M 0.5% | $5.2M 0.4% | $3.7M 0.3% | $2.9M 0.3% | $2.9M 0.4% | $1.9M 0.3% | $200K 0.0% | $392K 0.1% |
| Net Income | $247.1M 9.1% | $418.3M 20.2% | $206.3M 12.2% | $4.6M 0.4% | $16.8M 1.5% | $6.8M 0.8% | $11.6M 1.6% | $3.3M 0.6% | -$26.8M -5.8% | -$28.9M -7.9% |
| Per Share | ||||||||||
| EPS (Basic) | $3.51 | $5.97 | $2.96 | $0.07 | $0.25 | $0.11 | $0.19 | $0.06 | $-0.46 | $-0.48 |
| EPS (Diluted) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | $-0.46 | $-0.48 |
| Weighted Avg Shares (Basic) | 70.3M | 70.1M | 69.8M | 69.4M | 67.7M | 64.7M | 60.6M | 58.9M | 58.0M | 57.3M |
| Weighted Avg Shares (Diluted) | 71.9M | 73.9M | 73.6M | 69.9M | 68.6M | 65.9M | 62.3M | 61.0M | 58.0M | 57.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $60M buybacks = $60M returned on $378M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 16%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
$18M of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~322.8% on $18M of debt.
Cash vs short-term debt unavailable.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 34.3 | 34.9 | 35.6 | 31.6 | 38.3 | 31.7 | 30.2 | 28.4 |
| Gross Profit | 65.7 | 65.1 | 64.4 | 68.4 | 61.7 | 68.3 | 69.8 | 71.6 |
| R&D | 16.8 | 17.9 | 16.2 | 14.6 | 13.8 | 12.1 | 10.6 | 11.1 |
| SG&A | 44.0 | 40.4 | 42.5 | 42.4 | 45.0 | 43.3 | 44.3 | 43.0 |
| Operating Income | 4.9 | 6.8 | 5.7 | 11.5 | 2.9 | 13.0 | 14.9 | 17.5 |
| Income Tax | 0.3 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | -5.7 | 3.4 |
| Net Income | 0.6 | 1.6 | 0.8 | 1.5 | 0.4 | 12.2 | 20.2 | 9.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on PODD: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| PODD | $10.0B | 40.7× | 17.7× | 3.7× | 30.7% | 71.6% | 9.1% | 16.3% | 16.1% | 0.0× | 748 |
Peers = companies sharing PODD's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.